CCNI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.72750702631674E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.59774449016004E-13 |
Normal-vs-Stage2 |
1.56853999999651E-05 |
Normal-vs-Stage3 |
1.639600E-04 |
Normal-vs-Stage4 |
8.684200E-02 |
Stage1-vs-Stage2 |
5.696000E-01 |
Stage1-vs-Stage3 |
5.087000E-01 |
Stage1-vs-Stage4 |
4.546400E-01 |
Stage2-vs-Stage3 |
8.652800E-01 |
Stage2-vs-Stage4 |
7.092000E-01 |
Stage3-vs-Stage4 |
7.692600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.71140879245968E-12 |
Normal-vs-AfricanAmerican |
9.04109999977365E-07 |
Normal-vs-Asian |
4.4344000005303E-07 |
Caucasian-vs-AfricanAmerican |
2.995800E-01 |
Caucasian-vs-Asian |
3.376000E-01 |
AfricanAmerican-vs-Asian |
2.139200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.66533453693773E-15 |
Normal-vs-Female |
1.357260E-04 |
Male-vs-Female |
5.799900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.43289999998686E-06 |
Normal-vs-Extreme_Weight |
4.70301575461463E-12 |
Normal-vs-Obese |
3.71559999999826E-05 |
Normal-vs-Extreme_Obese |
1.12100000393411E-08 |
Normal_Weight-vs-Extreme_Weight |
5.291400E-01 |
Normal_Weight-vs-Obese |
2.234800E-01 |
Normal_Weight-vs-Extreme_Obese |
3.177600E-01 |
Extreme_Weight-vs-Obese |
2.917700E-02 |
Extreme_Weight-vs-Extreme_Obese |
4.656000E-01 |
Obese-vs-Extreme_Obese |
7.368200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.303800E-03 |
Normal-vs-Age(41-60Yrs) |
1.00910002576171E-09 |
Normal-vs-Age(61-80Yrs) |
1.63857816204427E-12 |
Normal-vs-Age(81-100Yrs) |
9.96450000000371E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.867400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.838800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.993800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.364390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.789000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.457400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.6251444634463E-12 |
Normal-VS-Type2 PRCC |
1.71940000015525E-08 |
Normal-VS-KIRP CIMP |
1.973210E-01 |
Normal-VS-Unclassified PRCC |
3.585100E-04 |
Type1 PRCC-VS-Type2 PRCC |
8.254400E-02 |
Type1 PRCC-VS-KIRP CIMP |
4.627500E-02 |
Type1 PRCC-VS-Unclassified PRCC |
4.637800E-02 |
Type2 PRCC-VS-KIRP CIMP |
2.687800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.650000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.011000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.90558679946662E-12 |
Normal-vs-N1 |
1.058360E-02 |
Normal-vs-N2 |
3.280000E-01 |
N0-vs-N1 |
7.439800E-02 |
N0-vs-N2 |
2.800000E-01 |
N1-vs-N2 |
9.639400E-01 |
|
|